Taro recalls 90,000 ibuprofen bottles

• 90,000 bottles recalled due to black particles
• Strides Pharma Inc. initiated recall after complaints
• Risk of harm remote, check product in cabinets

Nearly 90,000 bottles of Taro Pharmaceuticals' Children's Ibuprofen Oral Suspension have been recalled following reports of contaminants, including black

particles. The recall affects a product recommended for children aged 2 to 11 and was initiated after customer complaints. The Food and Drug Administration (FDA) issued a notice detailing the recall, which was prompted by reports of a gel-like mass and black specs in the medication. While the agency categorized the risk of serious health consequences as 'remote,' it underscores the importance of consumer safety.

Manufacturing and Recall Details

The medication was produced by Strides Pharma Inc. in India, a company known for manufacturing generic and over-the-counter medications. According to the FDA, Strides initiated the recall as a precautionary measure after receiving reports of contamination.

Strides Pharma Inc. has not yet commented on the recall, and Taro Pharmaceuticals also did not respond to requests for comments as of Friday morning.

FDA's Guidance on the Recall

The FDA's notice emphasized that the recall is a proactive measure aimed at ensuring consumer safety. While the agency has classified the potential health risks as minimal, it advises parents and guardians to check their medicine cabinets for the affected product.

The Children's Ibuprofen Oral Suspension is a berry-flavored liquid designed to relieve pain and reduce fever in children. The recall reflects the ongoing commitment of regulatory bodies to monitor and address safety issues in consumer products.